Multiple Novel Traits without Immediate Benefits Originate in Bacteria Evolving on Single Antibiotics
Open Access
- 3 December 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in Molecular Biology and Evolution
- Vol. 39 (1)
Abstract
How new traits originate in evolution is a fundamental question of evolutionary biology. When such traits arise, they can either be immediately beneficial in their environment of origin, or they may become beneficial only in a future environment. Compared to immediately beneficial novel traits, novel traits without immediate benefits remain poorly studied. Here we use experimental evolution to study novel traits that are not immediately beneficial but that allow bacteria to survive in new environments. Specifically, we evolved multiple E. coli populations in five antibiotics with different mechanisms of action, and then determined their ability to grow in more than 200 environments that are different from the environment in which they evolved. Our populations evolved viability in multiple environments that contain not just clinically relevant antibiotics, but a broad range of antimicrobial molecules, such as surfactants, organic and inorganic salts, nucleotide analogues and pyridine derivatives. Genome sequencing of multiple evolved clones shows that pleiotropic mutations are important for the origin of these novel traits. Our experiments, which lasted fewer than 250 generations, demonstrate that evolution can readily create an enormous reservoir of latent traits in microbial populations. These traits can facilitate adaptive evolution in a changing world.Keywords
Funding Information
- European Research Council
- Swiss National Science Foundation
This publication has 74 references indexed in Scilit:
- Clinically Relevant Mutant DNA Gyrase Alters Supercoiling, Changes the Transcriptome, and Confers Multidrug ResistancemBio, 2013
- A latent capacity for evolutionary innovation through exaptation in metabolic systemsNature, 2013
- Genomic analysis of a key innovation in an experimental Escherichia coli populationNature, 2012
- Evolutionary paths to antibiotic resistance under dynamically sustained drug selectionNature Genetics, 2011
- Synergistic Activities of an Efflux Pump Inhibitor and Iron Chelators against Pseudomonas aeruginosa Growth and Biofilm FormationAntimicrobial Agents and Chemotherapy, 2010
- Evolutionary noveltiesCurrent Biology, 2010
- Diamide Triggers Mainly S Thiolations in the Cytoplasmic Proteomes of Bacillus subtilis and Staphylococcus aureusJournal of Bacteriology, 2009
- Global phenotypic characterization of bacteriaFEMS Microbiology Reviews, 2008
- Engineering Pseudomonas putida S12 for Efficient Utilization of d -Xylose and l -ArabinoseApplied and Environmental Microbiology, 2008
- Historical contingency and the evolution of a key innovation in an experimental population ofEscherichia coliProceedings of the National Academy of Sciences, 2008